# Study of CU06-1004 in Patients With Daibetic Macular Edema

> **NCT07459829** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Curacle Co., Ltd.** · enrollment: 156 (estimated)

## Conditions studied

- DME
- Diabetic Macular Edema
- Diabetic Macular Edema (DME)

## Interventions

- **DRUG:** CU06-1004
- **DRUG:** Placebo Control

## Key facts

- **NCT ID:** NCT07459829
- **Lead sponsor:** Curacle Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-30
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459829, "Study of CU06-1004 in Patients With Daibetic Macular Edema". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07459829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*